| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/26/2013 | CA2457925C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 03/21/2013 | WO2013040556A1 Compositions of jasmonate compounds and methods of use |
| 03/21/2013 | WO2013038362A1 6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase |
| 03/21/2013 | WO2013038189A1 New enzyme inhibitor compounds |
| 03/21/2013 | WO2013038136A1 BI-AROMATIC AND TRI-AROMATIC COMPOUNDS AS NADPH OXIDASE 2 (Nox2) INHIBITORS |
| 03/21/2013 | WO2013038046A1 Use of trpa1 receptor antagonists for treating diseases associated with bacterial infections |
| 03/21/2013 | WO2013037960A1 Ep1 receptor ligands |
| 03/21/2013 | WO2013037862A1 Specific phosphatidylcholines as modulators of platelet activation factor activity |
| 03/21/2013 | WO2013037333A1 6, 8- disubstituted purine compositions and their pharmaceutical and cosmetic use |
| 03/21/2013 | WO2013037068A1 Method for treatment of disorders of the gastrointestinal system |
| 03/21/2013 | WO2012158932A3 REMOVAL OF α-GAL EPITOPES FROM THERAPEUTIC GLYCOPROTEINS FOR AVOIDING INTERACTION WITH THE ANTI-GAL ANTIBODY |
| 03/21/2013 | US20130072667 Use of rgm and its modulators |
| 03/21/2013 | US20130072575 Method and Composition for Treating Pain |
| 03/21/2013 | US20130072540 RNA interference of galectin-3 expression and methods of use thereof |
| 03/21/2013 | US20130072532 Topical transdermal dexmedetomidine compositions and methods of use thereof |
| 03/21/2013 | US20130072499 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS |
| 03/21/2013 | US20130072493 N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS |
| 03/21/2013 | US20130072482 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same |
| 03/21/2013 | US20130072481 mTOR SELECTIVE KINASE INHIBITORS |
| 03/21/2013 | US20130072470 Novel tricyclic compounds |
| 03/21/2013 | US20130072468 Substituted piperazines as cb1 antagonists |
| 03/21/2013 | US20130072452 Pharmaceutical composition and method for inhibiting inflammation |
| 03/21/2013 | US20130072445 Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 03/21/2013 | US20130072425 Saposin-a derived peptides and uses thereof |
| 03/21/2013 | US20130072421 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 03/21/2013 | US20130071493 Dietary supplement containing alkaline electrolyte butters |
| 03/21/2013 | US20130071466 Methods and compositions for treating gastric disorders |
| 03/21/2013 | US20130071438 Compositions and methods for the treatment of hyperplasia |
| 03/21/2013 | US20130071435 Novel herbal formulation for the modulation of immune system of hiv infected patients and a process of preparation thereof |
| 03/21/2013 | US20130071411 Iap bir domain binding compounds |
| 03/21/2013 | US20130071409 ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells |
| 03/21/2013 | US20130071342 Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care |
| 03/21/2013 | US20130071326 Universal cell-directed theranostics |
| 03/21/2013 | US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 03/21/2013 | CA2848809A1 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as c-met tyrosine kinase |
| 03/21/2013 | CA2848786A1 Ep1 receptor ligands |
| 03/21/2013 | CA2848762A1 Method for treatment of disorders of the gastrointestinal system |
| 03/21/2013 | CA2848219A1 Compositions of jasmonate compounds and methods of use |
| 03/21/2013 | CA2847266A1 New enzyme inhibitor compounds |
| 03/20/2013 | EP2570411A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 03/20/2013 | EP2570407A1 Tetrazole-substituted arylamide derivatives and their use as P2x3 and/or P2x2/3 purinergic receptor antagonists |
| 03/20/2013 | EP2570136A2 Protein A compositions and methods of use |
| 03/20/2013 | EP2570132A2 Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
| 03/20/2013 | EP2570125A1 Ep1 receptor ligands |
| 03/20/2013 | EP2570118A1 Combinations of hyaluronic acid and a vitamin for inhibiting inflammation |
| 03/20/2013 | EP2569431A1 Antisense modulation of interleukins 17 and 23 signaling |
| 03/20/2013 | EP2569318A1 Novel compounds |
| 03/20/2013 | EP2569317A1 Spirocyclic derivatives with affinity for calcium channels |
| 03/20/2013 | EP2569295A1 New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 03/20/2013 | EP2568997A2 Compositions and methods which modulate g-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis |
| 03/20/2013 | EP2568996A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| 03/20/2013 | EP2568991A1 Modulation of splenocytes in cell therapy |
| 03/20/2013 | EP2568824A1 Methods of control and prophylaxis of inflammation and mitigation of inflammatory conditions in companion animals |
| 03/20/2013 | EP2125795B1 Indole derivatives |
| 03/20/2013 | CN202802226U Ketoprofen-containing gel paste |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN102985426A Pyrazolo [1, 5A] pyrimidine and thieno [3, 2B] pyrimidine derivatives as IRAK4 modulators |
| 03/20/2013 | CN102985425A Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 03/20/2013 | CN102985424A 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases |
| 03/20/2013 | CN102985421A Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases |
| 03/20/2013 | CN102985418A Apoptosis signal-regulating kinase inhibitors |
| 03/20/2013 | CN102985417A Piperidin-4-yl azetidine derivatives as JAK1 inhibitors |
| 03/20/2013 | CN102985415A Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders |
| 03/20/2013 | CN102985405A Heterocyclic compound, and p27 kip1 degradation inhibitor |
| 03/20/2013 | CN102985103A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex |
| 03/20/2013 | CN102977215A Caspase-1 inhibitor targeting liver and application thereof |
| 03/20/2013 | CN102977213A Monoclonal antibodies against NKG2A |
| 03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
| 03/20/2013 | CN102977205A Novel osteoprotegerin variant proteins |
| 03/20/2013 | CN102977201A Scoropendra subspinipes mutilans polypeptide toxin mu-SLPTX-Ssm6a and gene and application thereof |
| 03/20/2013 | CN102977114A Inoscavin A as a monomeric component in phellinus as well as prepearation method and application thereof |
| 03/20/2013 | CN102977064A 4-chromone and 4-chromanone compounds and medical application thereof |
| 03/20/2013 | CN102974025A Disposable cervical dilator attached with medicine film |
| 03/20/2013 | CN102973920A Composition for treating respiratory diseases |
| 03/20/2013 | CN102973917A Blood activating and pain alleviating tablet |
| 03/20/2013 | CN102973888A Pills for treating rheumatic heart disease and preparation method thereof |
| 03/20/2013 | CN102973882A Traditional Chinese medicine for treating cervical spondylosis |
| 03/20/2013 | CN102973881A Traditional Chinese medicine for treating acute lumbar sprains |
| 03/20/2013 | CN102973873A Three kernel removing dampness tablets |
| 03/20/2013 | CN102973869A Chinese medicinal preparation for improving immunity, diminishing inflammation, removing stasis and eliminating toxicity |
| 03/20/2013 | CN102973868A Traditional Chinese medicine combination for treating ischialgia |
| 03/20/2013 | CN102973841A Traditional Chinese medicine used for treating arthromeningitis |
| 03/20/2013 | CN102973837A Medicine for external application to clear away heat and toxic materials and preparation method thereof |
| 03/20/2013 | CN102973834A Medicament for treating hyperpyrexia and cough with asthma of children |
| 03/20/2013 | CN102973831A Preparation method of Huaqi preparation |
| 03/20/2013 | CN102973830A Method for extracting flavonoid from asparagus |
| 03/20/2013 | CN102973826A Chinese laxative drug for removing fire factor |
| 03/20/2013 | CN102973820A Granules of Chinese patent drug for treating rheumatic and rheumatoid arthritis |
| 03/20/2013 | CN102973800A Puffball compound coating agent and preparation method thereof |
| 03/20/2013 | CN102973793A Health care wine |
| 03/20/2013 | CN102973762A Traditional Chinese medicine prescription used for treating lumbago caused by essence and blood loss of liver and kidney |
| 03/20/2013 | CN102973750A Chinese traditional medicine for curing rheumatic, rheumatoid and gouty arthritis and cervical spondylosis |
| 03/20/2013 | CN102973747A Bath fumigating liquid and preparation process thereof |
| 03/20/2013 | CN102973742A Traditional Chinese medicine sprayer fluid for treating traumatic sprain |
| 03/20/2013 | CN102973738A Traditional Chinese medicine composition for treating common cold due to wind cold |
| 03/20/2013 | CN102973734A Traditional Chinese medicine fumigating lotion for curing cervical, lumbar and dorsal muscle fasciitis |
| 03/20/2013 | CN102973721A Analgesic for rheumatism |
| 03/20/2013 | CN102973714A Traditional Chinese medicine composition for treating lumbar muscle strain and preparation method thereof |
| 03/20/2013 | CN102973712A Traditional Chinese medicine composition for treating knee joint rheumatalgia |
| 03/20/2013 | CN102973705A Strengthening bone pill |